Effects of lorazepam treatment for multiple ethanol withdrawals in mice (Q43940311)

28 November 2017

Effects of lorazepam treatment for multiple ethanol withdrawals in mice (English)

1 reference

28 November 2017

1 reference

Howard C Becker

1

1 reference

PubMed ID

11923591

28 November 2017

Lynn M Veatch

series ordinal

2

1 reference

28 November 2017

1 March 2002

1 reference

Alcoholism: Clinical and Experimental Research

28 November 2017

1 reference

28 November 2017

26

1 reference

28 November 2017

3

1 reference

28 November 2017

371-380

1 reference

Exacerbation of ethanol withdrawal seizures in mice with a history of multiple withdrawal experience

28 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Repeated ethanol withdrawal experience selectively alters sensitivity to different chemoconvulsant drugs in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Changes in seizure threshold and aggression during chronic treatment with three anticonvulsants and on drug withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

A permanent change in brain function resulting from daily electrical stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Benzodiazepine discontinuation syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Update on anticonvulsants for the treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Diazepam during prior ethanol withdrawals does not alter seizure susceptibility during a subsequent withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Management of the alcohol withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Diazepam prevents progression of kindled alcohol withdrawal behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

Sensitisation of withdrawal signs following repeated withdrawal from a benzodiazepine: differences between measures of anxiety and seizure sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02548.X

10.1111/J.1530-0277.2002.TB02548.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11923591